No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Integrin Beta 1 (ITGB1) is a protein found on the surface of cells that plays a role in cell adhesion and migration. In oncology, ITGB1 is a target for drug development, as it is involved in the growth and spread of cancer cells. ITGB1 inhibitors are being developed to block the activity of ITGB1, thus preventing cancer cells from growing and spreading.
ITGB1 inhibitors are being studied in a variety of cancer types, including breast, lung, and colorectal cancer. In addition, ITGB1 inhibitors are being studied in combination with other therapies, such as chemotherapy and immunotherapy, to improve the efficacy of treatment.
Several companies are developing ITGB1 inhibitors for the treatment of cancer. These include AstraZeneca, Merck, Pfizer, Novartis, and Bristol-Myers Squibb. Show Less Read more
